Anterix Inc. $ATEX Shares Sold by Y Intercept Hong Kong Ltd

by · The Cerbat Gem

Y Intercept Hong Kong Ltd lessened its position in shares of Anterix Inc. (NASDAQ:ATEX – Free Report) by 49.3% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 31,400 shares of the company’s stock after selling 30,512 shares during the quarter. Y Intercept Hong Kong Ltd owned approximately 0.17% of Anterix worth $674,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also made changes to their positions in ATEX. Garnet Equity Capital Holdings Inc. increased its holdings in shares of Anterix by 2.6% during the 2nd quarter. Garnet Equity Capital Holdings Inc. now owns 397,395 shares of the company’s stock worth $10,193,000 after buying an additional 10,000 shares during the last quarter. Geode Capital Management LLC lifted its stake in shares of Anterix by 8.7% in the second quarter. Geode Capital Management LLC now owns 383,557 shares of the company’s stock worth $9,840,000 after acquiring an additional 30,575 shares in the last quarter. Gamco Investors INC. ET AL raised its position in shares of Anterix by 35.0% in the 2nd quarter. Gamco Investors INC. ET AL now owns 273,425 shares of the company’s stock valued at $7,013,000 after purchasing an additional 70,855 shares in the last quarter. AYAL Capital Advisors Ltd boosted its stake in Anterix by 143.4% during the 2nd quarter. AYAL Capital Advisors Ltd now owns 240,171 shares of the company’s stock valued at $6,160,000 after acquiring an additional 141,500 shares during the last quarter. Finally, Bank of America Corp DE lifted its position in shares of Anterix by 25.2% during the second quarter. Bank of America Corp DE now owns 208,445 shares of the company’s stock worth $5,347,000 after purchasing an additional 42,018 shares during the last quarter. 87.67% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling at Anterix

In related news, insider Gena L. Ashe sold 6,564 shares of the stock in a transaction dated Tuesday, November 18th. The shares were sold at an average price of $21.07, for a total value of $138,303.48. Following the completion of the sale, the insider owned 13,366 shares in the company, valued at approximately $281,621.62. This trade represents a 32.94% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Scott A. Lang acquired 1,160 shares of the stock in a transaction dated Thursday, December 18th. The shares were purchased at an average price of $21.61 per share, for a total transaction of $25,067.60. Following the completion of the transaction, the chief executive officer owned 8,260 shares of the company’s stock, valued at $178,498.60. This trade represents a 16.34% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Company insiders own 45.61% of the company’s stock.

Anterix Price Performance

Shares of NASDAQ:ATEX opened at $27.45 on Tuesday. The stock has a market capitalization of $513.86 million, a P/E ratio of 5.37 and a beta of 0.86. The business has a 50-day moving average of $22.67 and a two-hundred day moving average of $21.81. Anterix Inc. has a fifty-two week low of $17.58 and a fifty-two week high of $42.91.

Anterix (NASDAQ:ATEX – Get Free Report) last posted its earnings results on Wednesday, November 12th. The company reported ($0.14) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.65) by $0.51. The business had revenue of $1.55 million for the quarter, compared to analyst estimates of $1.43 million. Anterix had a net margin of 1,614.08% and a negative return on equity of 14.95%. As a group, research analysts expect that Anterix Inc. will post -1.53 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of equities analysts have commented on ATEX shares. Weiss Ratings restated a “sell (d+)” rating on shares of Anterix in a research note on Wednesday, January 21st. JPMorgan Chase & Co. lowered their target price on shares of Anterix from $67.00 to $50.00 and set an “overweight” rating on the stock in a research note on Friday, October 17th. Finally, Zacks Research upgraded Anterix from a “hold” rating to a “strong-buy” rating in a report on Wednesday, January 7th. One analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating and one has given a Sell rating to the company. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $50.00.

Read Our Latest Report on ATEX

Anterix Profile

(Free Report)

Anterix, Inc is a specialized telecommunications company focused on delivering private broadband networks for utilities and other critical infrastructure industries. The company owns and operates dedicated 900 MHz spectrum that enables reliable, secure and high-performance wireless communications to support grid modernization, smart metering, distribution automation and other mission-critical applications. By leveraging this spectrum, Anterix helps electric, water and gas utilities deploy advanced communications capabilities to enhance operational efficiency and resiliency.

At the core of Anterix’s offering is its licensed 900 MHz spectrum, which provides superior propagation characteristics compared with unlicensed options and allows for cost-effective coverage over expansive service territories.

Read More